331 related articles for article (PubMed ID: 8321228)
1. Genetic evidence for in vivo cross-specificity of the CaaX-box protein prenyltransferases farnesyltransferase and geranylgeranyltransferase-I in Saccharomyces cerevisiae.
Trueblood CE; Ohya Y; Rine J
Mol Cell Biol; 1993 Jul; 13(7):4260-75. PubMed ID: 8321228
[TBL] [Abstract][Full Text] [Related]
2. Sequence dependence of protein isoprenylation.
Moores SL; Schaber MD; Mosser SD; Rands E; O'Hara MB; Garsky VM; Marshall MS; Pompliano DL; Gibbs JB
J Biol Chem; 1991 Aug; 266(22):14603-10. PubMed ID: 1860864
[TBL] [Abstract][Full Text] [Related]
3. Amino acid residues that define both the isoprenoid and CAAX preferences of the Saccharomyces cerevisiae protein farnesyltransferase. Creating the perfect farnesyltransferase.
Caplin BE; Ohya Y; Marshall MS
J Biol Chem; 1998 Apr; 273(16):9472-9. PubMed ID: 9545274
[TBL] [Abstract][Full Text] [Related]
4. Substrate characterization of the Saccharomyces cerevisiae protein farnesyltransferase and type-I protein geranylgeranyltransferase.
Caplin BE; Hettich LA; Marshall MS
Biochim Biophys Acta; 1994 Mar; 1205(1):39-48. PubMed ID: 8142482
[TBL] [Abstract][Full Text] [Related]
5. Amino acid substitutions that convert the protein substrate specificity of farnesyltransferase to that of geranylgeranyltransferase type I.
Del Villar K; Mitsuzawa H; Yang W; Sattler I; Tamanoi F
J Biol Chem; 1997 Jan; 272(1):680-7. PubMed ID: 8995312
[TBL] [Abstract][Full Text] [Related]
6. Peptide specificity of protein prenyltransferases is determined mainly by reactivity rather than binding affinity.
Hartman HL; Hicks KA; Fierke CA
Biochemistry; 2005 Nov; 44(46):15314-24. PubMed ID: 16285735
[TBL] [Abstract][Full Text] [Related]
7. Restricted substrate specificity for the geranylgeranyltransferase-I enzyme in Cryptococcus neoformans: implications for virulence.
Selvig K; Ballou ER; Nichols CB; Alspaugh JA
Eukaryot Cell; 2013 Nov; 12(11):1462-71. PubMed ID: 24014765
[TBL] [Abstract][Full Text] [Related]
8. CAAX geranylgeranyl transferase transfers farnesyl as efficiently as geranylgeranyl to RhoB.
Armstrong SA; Hannah VC; Goldstein JL; Brown MS
J Biol Chem; 1995 Apr; 270(14):7864-8. PubMed ID: 7713879
[TBL] [Abstract][Full Text] [Related]
9. Geranylgeranyltransferase I of Candida albicans: null mutants or enzyme inhibitors produce unexpected phenotypes.
Kelly R; Card D; Register E; Mazur P; Kelly T; Tanaka KI; Onishi J; Williamson JM; Fan H; Satoh T; Kurtz M
J Bacteriol; 2000 Feb; 182(3):704-13. PubMed ID: 10633104
[TBL] [Abstract][Full Text] [Related]
10. cDNA cloning and expression of rat and human protein geranylgeranyltransferase type-I.
Zhang FL; Diehl RE; Kohl NE; Gibbs JB; Giros B; Casey PJ; Omer CA
J Biol Chem; 1994 Feb; 269(5):3175-80. PubMed ID: 8106351
[TBL] [Abstract][Full Text] [Related]
11. Farnesylation and proteolysis are sequential, but distinct steps in the CaaX box modification pathway.
Farh L; Mitchell DA; Deschenes RJ
Arch Biochem Biophys; 1995 Apr; 318(1):113-21. PubMed ID: 7726551
[TBL] [Abstract][Full Text] [Related]
12. Efficient farnesylation of an extended C-terminal C(
Blanden MJ; Suazo KF; Hildebrandt ER; Hardgrove DS; Patel M; Saunders WP; Distefano MD; Schmidt WK; Hougland JL
J Biol Chem; 2018 Feb; 293(8):2770-2785. PubMed ID: 29282289
[TBL] [Abstract][Full Text] [Related]
13. Purified yeast protein farnesyltransferase is structurally and functionally similar to its mammalian counterpart.
Gomez R; Goodman LE; Tripathy SK; O'Rourke E; Manne V; Tamanoi F
Biochem J; 1993 Jan; 289 ( Pt 1)(Pt 1):25-31. PubMed ID: 8424764
[TBL] [Abstract][Full Text] [Related]
14. Crystallographic analysis of CaaX prenyltransferases complexed with substrates defines rules of protein substrate selectivity.
Reid TS; Terry KL; Casey PJ; Beese LS
J Mol Biol; 2004 Oct; 343(2):417-33. PubMed ID: 15451670
[TBL] [Abstract][Full Text] [Related]
15. Protein Farnesyltransferase Catalyzes Unanticipated Farnesylation and Geranylgeranylation of Shortened Target Sequences.
Ashok S; Hildebrandt ER; Ruiz CS; Hardgrove DS; Coreno DW; Schmidt WK; Hougland JL
Biochemistry; 2020 Mar; 59(11):1149-1162. PubMed ID: 32125828
[TBL] [Abstract][Full Text] [Related]
16. Structural homology among mammalian and Saccharomyces cerevisiae isoprenyl-protein transferases.
Kohl NE; Diehl RE; Schaber MD; Rands E; Soderman DD; He B; Moores SL; Pompliano DL; Ferro-Novick S; Powers S
J Biol Chem; 1991 Oct; 266(28):18884-8. PubMed ID: 1918005
[TBL] [Abstract][Full Text] [Related]
17. Time-dependent inhibition of protein farnesyltransferase by a benzodiazepine peptide mimetic.
Roskoski R; Ritchie PA
Biochemistry; 2001 Aug; 40(31):9329-35. PubMed ID: 11478901
[TBL] [Abstract][Full Text] [Related]
18. Polylysine and CVIM sequences of K-RasB dictate specificity of prenylation and confer resistance to benzodiazepine peptidomimetic in vitro.
James GL; Goldstein JL; Brown MS
J Biol Chem; 1995 Mar; 270(11):6221-6. PubMed ID: 7890759
[TBL] [Abstract][Full Text] [Related]
19. Suppression of yeast geranylgeranyl transferase I defect by alternative prenylation of two target GTPases, Rho1p and Cdc42p.
Ohya Y; Qadota H; Anraku Y; Pringle JR; Botstein D
Mol Biol Cell; 1993 Oct; 4(10):1017-25. PubMed ID: 8298188
[TBL] [Abstract][Full Text] [Related]
20. CDC43 and RAM2 encode the polypeptide subunits of a yeast type I protein geranylgeranyltransferase.
Mayer ML; Caplin BE; Marshall MS
J Biol Chem; 1992 Oct; 267(29):20589-93. PubMed ID: 1400380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
